Suppr超能文献

基于 CT 的椎体骨密度是预测 COVID-19 结局的有用生物标志物。

CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome.

机构信息

Division of Pulmonary Medicine, Department of Medicine, Keio University, School of Medicine, Tokyo, Japan.

Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Bone. 2024 Jul;184:117095. doi: 10.1016/j.bone.2024.117095. Epub 2024 Apr 8.

Abstract

The low vertebral bone computed tomography (CT) Hounsfield unit values measured on CT scans reflect low bone mineral density (BMD) and are known as diagnostic indicators for osteoporosis. The potential prognostic significance of low BMD defined by vertebral bone CT values for the coronavirus disease 2019 (COVID-19) remains unclear. This study aimed to assess the impact of BMD on the clinical outcome in Japanese patients with COVID-19 and evaluate the association between BMD and critical outcomes, such as high-flow nasal cannula, non-invasive and invasive positive pressure ventilation, extracorporeal membrane oxygenation, or death. We examined the effects of COVID-19 severity on the change of BMD over time. This multicenter retrospective cohort study enrolled 1132 inpatients with COVID-19 from the Japan COVID-19 Task Force database between February 2020 and September 2022. The bone CT values of the 4th, 7th, and 10th thoracic vertebrae were measured from chest CT images. The average of these values was defined as BMD. Furthermore, a comparative analysis was conducted between the BMD on admission and its value 3 months later. The low BMD group had a higher proportion of critical outcomes than did the high BMD group. In a subanalysis stratifying patients by epidemic wave according to onset time, critical outcomes were higher in the low BMD group in the 1st-4th waves. Multivariable logistic analysis of previously reported factors associated with COVID-19 severity revealed that low BMD, chronic kidney disease, and diabetes were independently associated with critical outcomes. At 3 months post-infection, patients with oxygen demand during hospitalization showed markedly decreased BMD than did those on admission. Low BMD in patients with COVID-19 may help predict severe disease after the disease onset. BMD may decrease over time in patients with severe COVID-19, and the impact on sequelae symptoms should be investigated in the future.

摘要

低椎体骨计算机断层扫描(CT)Hounsfield 单位值反映了低骨密度(BMD),并作为骨质疏松症的诊断指标。由椎体 CT 值定义的低 BMD 对 2019 年冠状病毒病(COVID-19)的潜在预后意义尚不清楚。本研究旨在评估 BMD 对 COVID-19 日本患者临床结局的影响,并评估 BMD 与高流量鼻导管、无创和有创正压通气、体外膜氧合或死亡等危重结局之间的关系。我们检查了 COVID-19 严重程度对 BMD 随时间变化的影响。这项多中心回顾性队列研究纳入了 2020 年 2 月至 2022 年 9 月期间,来自日本 COVID-19 工作组数据库的 1132 例 COVID-19 住院患者。从胸部 CT 图像中测量第 4、7 和 10 胸椎的 CT 值。这些值的平均值定义为 BMD。此外,还对入院时的 BMD 与其 3 个月后的数值进行了比较分析。低 BMD 组比高 BMD 组更有可能出现危重结局。根据发病时间按流行波分层的患者亚分析显示,第 1-4 波的低 BMD 组危重结局发生率更高。对与 COVID-19 严重程度相关的先前报道因素的多变量逻辑分析显示,低 BMD、慢性肾脏病和糖尿病与危重结局独立相关。在感染后 3 个月,住院期间有氧气需求的患者的 BMD 明显低于入院时。COVID-19 患者的低 BMD 可能有助于预测发病后严重疾病。在 COVID-19 严重患者中,BMD 可能随时间降低,未来应调查其对后遗症症状的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验